Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,525 | 14,625 | 9,954 | 6,678 | 2,649 |
| Receivables | N/A | N/A | N/A | 405 | 339 |
| Other current assets | 0 | 0 | 0 | 39 | 557 |
| TOTAL | $19,073 | $16,216 | $12,463 | $7,122 | $3,545 |
| Non-Current Assets | |||||
| PPE Net | 65 | 37 | 223 | 323 | 475 |
| Other Non-Current Assets | 6 | 4 | 737 | 31 | 91 |
| TOTAL | $71 | $41 | $960 | $354 | $566 |
| Total Assets | $19,144 | $16,257 | $13,423 | $7,476 | $4,111 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 996 | 142 | 395 | 388 | 266 |
| Accrued Expenses | 1,836 | 885 | 0 | 29 | 210 |
| Other current liabilities | 6,756 | N/A | N/A | N/A | N/A |
| TOTAL | $9,588 | $1,027 | $395 | $417 | $500 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | -1 | 0 | 0 | 32 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $32 |
| Total Liabilities | $9,588 | $1,027 | $395 | $417 | $532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8 | 7 | 5 | 4 | 3 |
| Common Shares | 72 | 58 | 44 | 31 | 23 |
| Retained earnings | -101,042 | -81,258 | -68,941 | -51,873 | -43,724 |
| TOTAL | $9,556 | $15,230 | $13,028 | $7,059 | $3,579 |
| Total Liabilities And Equity | $19,144 | $16,257 | $13,423 | $7,476 | $4,111 |